Dysregulation of HSG triggers vascular proliferative disorders
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Vascular proliferative disorders, such as atherosclerosis and restenosis, are the most common causes of severe cardiovascular diseases, but a common molecular mechanism remains elusive. Here, we identify and characterize a novel hyperplasia suppressor gene, named HSG (later re-named rat mitofusin-2). HSG expression was markedly reduced in hyper-proliferative vascular smooth muscle cells (VSMCs) from spontaneously hypertensive rat arteries, balloon-injured Wistar Kyoto rat arteries, or ApoE-knockout mouse atherosclerotic arteries. Overexpression of HSG overtly suppressed serum-evoked VSMC proliferation in culture, and blocked balloon injury induced neointimal VSMC proliferation and restenosis in rat carotid arteries. The HSG anti-proliferative effect was mediated by inhibition of ERK/MAPK signalling and subsequent cell-cycle arrest. Deletion of the p21(ras) signature motif, but not the mitochondrial targeting domain, abolished HSG-induced growth arrest, indicating that rHSG-induced anti-proliferation was independent of mitochondrial fusion. Thus, rHSG functions as a cell proliferation suppressor, whereas dysregulation of rHSG results in proliferative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Besides its role in mitochondrial fusion, Mfn2 has been described to be involved in the regulation of cell proliferation, oxidative metabolism, autophagy, mitophagy, mitochondrial antiviral signaling, and unfolded protein response (Bach et al, 2003; Chen et al, 2004; Yasukawa et al, 2009; Hailey et al, 2010; Ngoh et al, 2012; Zhao et al, 2012; Chen & Dorn, 2013; Munoz et al, 2013).”
From Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway (2016) · cites this paper as Chen et al, 2004
In the citing paper
“Recently, it has been reported that Mfn2 binds Ras and its overexpression inhibits extracellular signalrelated kinase/mitogen-activated protein kinase signaling and subsequently arrests cell cycle (30).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [30]
Citations
Cites
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224 · cited 1×
“Recent studies indicate that coated stents with anti-proliferative agents, including rapamyci”
BackgroundMarshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906 · cited 1×
“The Ras proto-oncogene is a central component of mitogenic signalling pathways, and is essential for cells to exit a quiescent state (G0) and to pass through the G1–S transition of the cell cycl”
BackgroundChen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., & Chan, D. C. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211046 · Cited by 2,601 · cited 1×
“Several studies have demonstrated that human Mfn-2 and its homologues localize to the mitochondrial outer membrane and have an essential role in mitochondrial fusion, thus regulating mitochondrial morphology and function in mammalian cells, yeast and flie”
BackgroundDevelopment of a Strain of Spontaneously Hypertensive Rats
OKAMOTO, K., & AOKI, K. (1963) · Japanese Circulation Journal · doi:10.1253/jcj.27.282 · Cited by 2,545
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L.-H., Broudy, V., Perlmutter, R. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81239-8 · Cited by 1,457
Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., & Ruokokoski, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04021-0 · Cited by 1,444
Clowes, A. W., Reidy, M. A., & Clowes, M. M. (1983) · PubMed · Cited by 1,437
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., & Chang, E. H. (1990) · Nature · doi:10.1038/348747a0 · Cited by 1,211 · cited 1×
“In fact, the anti-proliferative effect of human HSG is more potent than that induced by overexpression of p53, a well established tumour suppresso”
Background
Cited by
Items 201–300 of 368
Mitofusin 2: A link between mitochondrial function and substrate metabolism?
Emery, J., & Ortiz, R. M. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.09.003 · Cited by 37
Effect of Mitofusin 2 on smooth muscle cells proliferation in hypoxic pulmonary hypertension
Zhang, D., Ma, C., Li, S., Ran, Y., Chen, J., Lü, P., Shi, S., & Zhu, D. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.06.010 · Cited by 31
Mitochondrial Dynamics and Heart Failure
Knowlton, A. A., & Liu, T. (2015) · Comprehensive physiology · doi:10.1002/cphy.c150022 · Cited by 33
Li, D. X., Li, X., Guan, Y., & Guo, X. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv035 · Cited by 33
Self-citationMitofusin-2: A New Mediator of Pathological Cell Proliferation
Xin, Y., Li, J., Wu, W., & Liu, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.647631 · Cited by 32
“, 2012), atherosclerosis, hypertension (Chen et al., 2004),”
BackgroundMitochondrial Dynamism and Cardiac Fate: A Personal Perspective
Dorn, G. W. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0453 · Cited by 30
Mitofusin 2, a key coordinator between mitochondrial dynamics and innate immunity
Kim, I. S., Silwal, P., & Jo, E. (2021) · Virulence · doi:10.1080/21505594.2021.1965829 · Cited by 29
Li, Y., Dong, W., Shan, X., Hong, H., Liu, Y., Liu, Y., Liu, X., Zhang, X., & Zhang, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.8314 · Cited by 32
“Mitofusin 2 ( Mfn2 ), also named hyperperplasia suppressor gene ( HSG ), is expressed in numerous human tissues and serves a pivotal role in the proliferation and apoptosis of vascular smooth muscle cells (VSMCs) (3,4).”
InfluentialChanges in the expression of cardiac mitofusin-2 in different stages of diabetes in rats
Gao, Q. F., Wang, X., Ye, H., Yu, Y., Kang, P., Wang, H., Guan, S., & Li, Z. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1002 · Cited by 28
“The overexpression of Mfn2 inhibited the proliferation of hyper-proliferative vascular smooth muscle cells in vitro and in vivo (19).”
BackgroundLipskaia, L., Bobe, R., Chen, J., Turnbull, I. C., López, J. J., Merlet, E., Jeong, D., Karakikes, I., Ross, A. S., Liang, L., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002565 · Cited by 30
Segalés, J., Paz, J. C., Hernández‐Álvarez, M. I., Sala, D., Muñoz, J. P., Noguera, E., Pich, S., Palacín, M., Enríquez, J. A., & Antonio Zorzano, A. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00546.2012 · Cited by 29
“Thus, Mfn2 has pleiotropic cellular roles and regulates cell proliferation, oxidative metabolism, autophagy, and mitochondrial antiviral signaling protein (4, 13, 22, 37, 51).”
BackgroundJanjanam, J., Zhang, B., Mani, A. M., Singh, N. K., Traylor, J. G., Orr, A. W., & Rao, G. N. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000866 · Cited by 28
“Because VSMC multiplication is a common factor in restenosis and during the early development of atherosclerosis (24, 36), the above observations further infer that LMCD1 via enhancing VSMC replication can promote the pathogenesis of atherosclerosis as well.”
BackgroundMa, L., Liu, Y., Geng, C., Qi, X., & Jiang, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3695 · Cited by 26
Sonic hedgehog signaling regulates hypoxia/reoxygenation‑induced H9C2 myocardial cell apoptosis
Zhang, R., Qiao, Z., Liu, H., & Ma, J. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6678 · Cited by 29
Lin, C., Lv, X., Yuan, F., Li, X., Ma, M., Liu, C., Zhou, J., Wang, G., & Guan, Y. (2017) · Circulation Journal · doi:10.1253/circj.cj-17-0585 · Cited by 25
Mfn2 inhibits proliferation and cell-cycle in Hela cells via Ras-NF-κB signal pathway
Liu, X., Sun, J., Yuan, P., Shou, K., Zhou, Y., Gao, W., She, J., Hu, J. X., Yang, J., & Yang, J. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0916-9 · Cited by 28
Zhao, G., Yao, Y.-M., Lu, Z., Hong, G., Zhu, X.-M., Wu, Y., Wang, D., Dong, N., Yu, Y., & Sheng, Z.-Y. (2012) · Cytokine · doi:10.1016/j.cyto.2012.03.026 · Cited by 26
HSG/Mfn2 Gene Polymorphism and Essential Hypertension: a Case-Control Association Study in Chinese
Wang, Z., Liu, Y., Liu, J., Liu, K., Wen, J., Wen, S., & Wu, Z. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.5611 · Cited by 24
Self-citationRole of Mitofusin-2 in High Mobility Group Box-1 Protein-Mediated Apoptosis of T Cellsin Vitro
Wu, Z., Yao, Y.-M., Hong, G., Xu, X., Liu, Y., Dong, N., Zheng, J., Lu, Z., Zhao, G., Zhu, X.-M., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358651 · Cited by 24
Mitofusin-2 is required for mouse oocyte meiotic maturation
Zhang, J., Zhang, T., Gao, S., Wang, K., Yang, X.-Y., Mo, F., Yu, N., An, T., Li, Y., Hu, J.-W., et al. (2016) · Scientific Reports · doi:10.1038/srep30970 · Cited by 24
HSG provides antitumor efficacy on hepatocellular carcinoma both in vitro and in vivo
Zheng (2010) · Oncology Reports · doi:10.3892/or_00000844 · Cited by 23
“Over-expression Over-expression of HSG inhibited mitogenetic stimuli-or injury-induced VSMC proliferation, and prevented balloon injury induced re-stenosis and reduced atherosclerosis (10).”
Chiaratti, M. R. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00891-w · Cited by 27
Li, Q., Li, G., Lan, X., Zheng, M., Chen, K., Cao, C., & Xiao, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.071332 · Cited by 24
Self-citationMitofusin-2 Triggers Cervical Carcinoma Cell Hela Apoptosis via Mitochondrial Pathway in Mouse Model
Wang, W., Liu, X., Guo, X., & Quan, H. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488410 · Cited by 23
Self-citationDVT: A New Era in Anticoagulant Therapy
Mackman, N., & Becker, R. C. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.203497 · Cited by 25
Mitochondrial Dysfunction in the Cardio-Renal Axis
Méndez‐Barbero, N., Oller, J., Sanz, A. B., Ramos, A. M., Ortíz, A., Ruiz‐Ortega, M., & Rayego‐Mateos, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098209 · Cited by 28
Liu, C., Ge, B., He, C., Zhang, Y., Liu, X., Liu, K., Qian, C., Zhang, Y., Peng, W., & Guo, X. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.005 · Cited by 22
Self-citationD. melanogaster, mitochondria and neurodegeneration: small model organism, big discoveries
Debattisti, V., & Scorrano, L. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.08.007 · Cited by 25
Mitochondrial Dynamics Impairment in Dexamethasone-Treated Neuronal Cells
Suwanjang, W., Wu, K. L. H., Prachayasittikul, S., Chetsawang, B., & Charngkaew, K. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02779-4 · Cited by 23
Role of GTPase-Dependent Mitochondrial Dynamins in Heart Diseases
Liu, J., Song, X., Yan, Y., & Liu, B. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.720085 · Cited by 24
Guo, Y., Chen, F., Wang, G., Chen, L., & Gao, W. Q. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200811020-00011 · Cited by 20
Self-citationAntonio Zorzano, A., & Pich, S. (2006) · IUBMB Life · doi:10.1080/15216540600644838 · Cited by 19
“…expression is markedly down-regulated in hyper-proliferative vascular smooth muscle from spontaneously hypertensive rat arteries, balloon-injured Wistar Kyoto rat arteries and Apo E-knockout atherosclerotic mouse, and is activated during mitogen stimulation of smooth muscle cells in vitro ( 13 ).”
BackgroundInfluentialMechanism of Activation-Induced Downregulation of Mitofusin 2 in Human Peripheral Blood T Cells
Dasgupta, A., Chen, K., Munk, R. B., Sasaki, C. Y., Curtis, J., Longo, D. L., & Ghosh, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501023 · Cited by 20
“Whole-cell lysates were prepared as described previously (9).”
BackgroundMethodSelf-citationMitofusin-2 Expression Is Implicated in Cervical Cancer Pathogenesis
Ahn, S. Y., Li, C., Zhang, X., & Hyun, Y. (2018) · Anticancer Research · doi:10.21873/anticanres.12610 · Cited by 20
Integrated analysis of tRNA-derived small RNAs in proliferative human aortic smooth muscle cells
Zhao, J., Li, Q.-Y., Lin, J., Yang, L., Du, M.-Y., Wang, Y., Liu, K., Jiang, Z.-A., Li, H., Wang, S., et al. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00346-4 · Cited by 21
Self-citationZhang, Q., Zhang, Y., Xie, B., Liu, D., Wang, Y., Zhou, Z., Zhang, Y., King, E., Tse, G., & Liu, T. (2023) · Cancer Innovation · doi:10.1002/cai2.64 · Cited by 21
“Studies have shown that MFN2 plays an important role in regulating cellular energy metabolism, proliferation and apoptosis, and signal transduction [24 – 27].”
BackgroundWang, W., Zhou, D., Wei, J., Wu, Z., Cheng, X., Sun, Q., Xie, H., Zhou, L., & Zheng, S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.015 · Cited by 19
Tang, W., Cui, T., Ben, W., Wu, W., & Fu, P. (2012) · Journal of Nephrology · doi:10.5301/jn.5000089 · Cited by 19
Shi, Y., Yi, C., Li, X., Wang, J., Zhou, F., & Chen, X. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.12.052 · Cited by 20
“Accepted Manuscript Title: Overexpression of Mitofusin2 decreased the reactive astrocytes proliferation in vitro induced by oxygen-glucose deprivation/reoxygenation Author: Yulong Shi Chengla Yi Xiao Li Jiangpeng Wang Fangyuan Zhou Xiaoqian Chen PII: S0304-3940(16)31000-”
BackgroundInfluentialRelationship between mitofusin 2 and cancer
Allegra, A., Innao, V., Allegra, A. G., & Musolino, C. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.11.009 · Cited by 25
Luo, F., Liu, W., & Bu, H. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10231-z · Cited by 17
“MFN2 mainly inhibits the proliferation of vascular smooth muscle cells by inhibiting Ras extracellular signal regulated kinase (ERK1/2) [71], and the ERK1/2 pathway is involved in the development of myocardial hypertrophy [72].”
BackgroundOverexpression of mitofusin 2 inhibits reactive astrogliosis proliferation in vitro
Liu, T., Xue, C., Shi, Y., Bai, X., Li, Z., & Yi, C. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.002 · Cited by 19
Mitofusin-2 is a novel anti-angiogenic factor in pancreatic cancer
Lin, Z., Lin, X., Chen, J., Huang, G., Chen, T., & Zheng, L. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-176 · Cited by 17
“Additionally, MFN2 acts as a suppressor of cell proliferation in different cell models and is considered an anti-tumor gene in cancer (2,15,16).”
BackgroundKoncsos, G., Varga, Z. V., Baranyai, T., Ferdinándy, P., Schulz, R., Giricz, Z., & Boengler, K. (2018) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2018.01.004 · Cited by 19
Liao, H., Gong, J., Zhang, W., & Guo, X. (2012) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-012-0005-y · Cited by 18
Self-citationLiu, P., Gao, S., Li, Z., Pan, S., Luo, G., & Ji, Z. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175725 · Cited by 18
Chen, H., Lu, Y. F., Qi, Y., Bai, W., & Liao, Q. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.11.024 · Cited by 17
“Studies on other tissues mostly agree that Mfn2 is related to cell aging (by affecting mitochondrial fusion) [25–27], proliferation and apoptosis (through the RAS signaling pathway) [28,29].”
BackgroundJin, F., Li, X., Wang, Z., Liu, Y., Liu, J., Sun, D., Jin, Y., Wang, S., Wen, S., & Wei, Y. (2018) · Hypertension Research · doi:10.1038/s41440-018-0057-x · Cited by 17
Self-citationRegulation of Myosin Light Chain Kinase Expression by Angiotensin II in Hypertension
Han, Y.-J., Hu, W., Piano, M. R., & de Lanerolle, P. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.199 · Cited by 17
Wang, Z., Niu, Q., Peng, X., Li, M., Liu, K., Liu, Y., Liu, J., Jin, F., Li, X., & Wei, Y. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.007 · Cited by 17
Vascular Stenosis: An Introduction
Thiriet, M., Delfour, M. C., & Garon, A. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_32 · Cited by 20
Mitofusin 2 mutation drives cell proliferation in Charcot-Marie-Tooth 2A fibroblasts
Zanfardino, P., Longo, G., Amati, A., Morani, F., Picardi, E., Girolamo, F., Pafundi, M., Cox, S. N., Manzari, C., Tullo, A., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac201 · Cited by 18
Tissue-Specific Effects of Bariatric Surgery Including Mitochondrial Function
Dankel, S. N., Staalesen, V., Bjørndal, B., Berge, R. K., Mellgren, G., & Burri, L. (2011) · Journal of Obesity · doi:10.1155/2011/435245 · Cited by 17
“Furthermore, it has been proposed that mitochondrial fusion and metabolism in obese and non-obese T2DM patients is impaired due to reduced expression of mitofusin 2 (MFN2) in skeletal muscle [82–84].”
BackgroundBlanc, S. L., Villarroel, P., Candia, V., Gavilán, N., Néstor Soto, I., Pérez‐Bravo, F., & Arredondo, M. (2012) · BioMetals · doi:10.1007/s10534-012-9540-z · Cited by 16
“In addition, Mfn2 was recently described as an anti-proliferative protein involved in vascular disorders (Chen et al. 2004).”
BackgroundMaimaitijiang, A., Zhuang, X., Jiang, X., & Li, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.051 · Cited by 19
“Importantly, Mfn2 overexpression via viral transfection significantly inhibited restenosis after balloon dilation[12].”
BackgroundZhang, X., Chen, W.-J., Li, J., Qi, S., Hong, S., Wang, Y., Gao, L., Shi, Z., Liu, Y., Liu, W., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.048 · Cited by 17
Ryu, S., Choi, K., Park, J., Park, Y., Kim, S., & Choi, C. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.038 · Cited by 17
“Putative functional differences between Mfn1 and Mfn2 in mitochondrial fusion have been identified [11,33,43–46].”
A genetic mouse model of lean-NAFLD unveils sexual dimorphism in the liver-heart axis
Burelle, C., Clapatiuc, V., Deschênes, S., Cuillerier, A., Loof, M. D., Higgins, M., Boël, H., Daneault, C., Chouinard, B., Clavet‐Lanthier, M., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06035-6 · Cited by 15
“Moreover, in explanted failing human heart samples and in a rat heart failure model, OPA1 protein level was signi fi cantlyreduced,eventhough Mfn1/2 geneandproteinlevelsremained unchanged 51 .”
Mitochondrial quality control: Biochemical mechanism of cardiovascular disease
Inferrera, F., Marino, Y., Genovese, T., Cuzzocrea, S., Fusco, R., & Paola, R. D. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.119906 · Cited by 18
Shu, Z., Yu, M., Zeng, G., Zhang, X., Wu, L., & Tan, X. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2014.04.001 · Cited by 15
Keller, A. C., Knaub, L. A., McClatchey, P. M., Connon, C. A., Bouchard, R. J., Miller, M. W., Geary, K. E., Walker, L. A., Klemm, D. J., & Reusch, J. E. B. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8524267 · Cited by 14
“Other studies observe that dysregulated mitochondrial fusion, seen across animal models of cardiovascular disease, is central to this disease progression [6, 17, 20, 57].”
BackgroundZhang, X., Xu, X., Lü, L., Wan, X., Qin, Y., Ruan, W., Lv, C., He, L., & Guo, X. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03064-1 · Cited by 15
“Our previous studies have demonstrated that Mfn-2 acts as an endogenous Ras inhibitor and has critical roles in cell apoptosis and vascular proliferative disorders [12, 13].”
BackgroundSelf-citationProteolytic regulation of mitochondrial dynamics
Dietz, J. V., Bohovych, I., Viana, M. P., & Khalimonchuk, O. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.04.008 · Cited by 15
Role of mitochondrial metabolism in immune checkpoint inhibitors-related myocarditis
Zhang, X., Gan, Y., Zhu, H., Liu, Z., Yao, X., Cheng, C., Liu, Z., Su, C., & Zou, J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1112222 · Cited by 21
“MFN2 encodes a GTPase protein located on the outer mitochondrial membrane and was originally found in smooth muscle cells (35).”
BackgroundFrohman, M. A. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0662-x · Cited by 16
“Xiao in this collection, Mfn2 was independently identified as a protein that suppresses Rasmediated hyperproliferation of vascular smooth muscle cells in spontaneously hypertensive rats, via a mechanism, potentially involving the promotion of apoptosis that is distinct from its function in mediating mitochondrial fusi…”
BackgroundPrognostic impact of mitofusin 2 expression in colon cancer
Cheng, X., Li, Y., & Liu, F. (2022) · Translational Cancer Research · doi:10.21037/tcr-22-589 · Cited by 14
“It was initially identified in the vascular smooth muscle cells of spontaneously hypertensive rats (6).”
Wang, Z., Niu, Q., Peng, X., Li, M., Liu, Y., Liu, J., Wen, S., & Wei, Y. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.10.122 · Cited by 14
Self-citationEmon, I. M., Al‐Qazazi, R., Rauh, M. J., & Archer, S. L. (2023) · Cells · doi:10.3390/cells12212528 · Cited by 14
“MFN2 is an inhibitor of smooth muscle cell proliferation [67], and DNMT1-mediated inhibition of MFN2’s expression in VSMCs favours the proliferation and formation of atherosclerotic plaques [66].”
BackgroundRole of mitofusin 2 in cardiovascular oxidative injury
Zheng, M., & Xiao, R. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0675-5 · Cited by 14
“In vivo and in vitro studies have shown that MFN2 also exhibits a profound antiproliferative effect, independently of its role in mitochondrial fusion [4].”
InfluentialSelf-citationHuang, S., Chen, Z., Wu, W., Wang, M., Wang, R., Cui, J., Li, W., & Wang, S. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5453 · Cited by 13
“…gene, has a crucial role in regulating cell proliferation, migration, apoptosis and differentiation, which are involved in the pathophysiological processes of severe cardiovascular diseases, including atherosclerosis, restenosis after angioplasty, hypertension and myocardial infarction (29-31).”
Hao, Y., Yang, Z., Li, Q., Wang, Z., Liu, J., & Wang, J. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202101114 · Cited by 13
Self-citationChen, I., Liu, Y., Wu, Y.-H., Lo, S., Wang, S., Li, C., Dai, Z., Hsu, J., Yeh, C.-Y., & Tseng, Y. (2022) · Biomedicines · doi:10.3390/biomedicines10040873 · Cited by 14
“It is worth noting that MFN2 was initially referred to as a hyperplasia suppressor gene when it was cloned because of its anti-proliferative effect [11,12], and has been reported to regulate cell proliferation and the apoptosis of multiple tumor cell lines and vascular smooth muscle cells [13,14].”
BackgroundChen, B., Zhong, L., Yang, J., Pan, Y., Chen, F., Yang, J., Wu, T., & Hu, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000356610 · Cited by 13
Antiproliferative effect of panaxynol on RASMCs via inhibition of ERK1/2 and CREB
Jiang, L., Yang, L., Nie, B., & Chen, H. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2007.11.013 · Cited by 13
Dan, J., Sun, X., Li, W., Zhang, Y., Li, X., Xu, H., Li, Z., Tian, Z., Guo, S., Yao, J., et al. (2015) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2014.12.664 · Cited by 12
Function and regulation of mitofusin 2 in cardiovascular physiology and pathology
Yu, F., Xu, T., Wang, M., Chang, W., Li, P., & Wang, J. (2018) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2018.07.003 · Cited by 15
Self-citationJiang, G.-J., Han, M., Zheng, B., & Wen, J. (2006) · Heart and Vessels · doi:10.1007/s00380-006-0914-4 · Cited by 12
“Hyperplasia suppressor gene (HSG) was initially identified by screening the VSMC cDNA library of Wistar-Kyoto rats (WKY) and spontaneous hypertension rats (SHR) using a differential display technique.(7) The HSG cDNA fragment was highly expressed in WKY but weakly expressed in SHR.”
BackgroundMethodInfluentialMitochondria at the crossroads of aging and cardiovascular disease
Lateef, O. M., Fakorede, S., Harris, C., Lateef, A. M., & Ajayi, A. F. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.124127 · Cited by 11
Adiponectin Protects Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Suppressing Autophagy
Guo, J., Zhu, K., Li, Z., & Xiao, C. (2022) · Journal of Immunology Research · doi:10.1155/2022/8433464 · Cited by 12
“Cell viability was quanti fi ed by measuring absorbance (optical density) at 490 nm on a microplate reader and expressed as the fold change relative to that in vehicle control treatment (PBS) as described previously [20, 22].”
Inagaki, S., Suzuki, Y., Kawasaki, K., Kondo, R., Imaizumi, Y., & Yamamura, H. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.01.044 · Cited by 13
Li, M., Zhang, B., Li, C., Liu, J., Liu, Y., Sun, D., Ma, H., & Wen, S. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.13012 · Cited by 10
“Overexpression of Mfn2 overtly suppressed serum-evoked VSMC proliferation in vitro and this anti-proliferative effect was mediated by inhibiting extracellular signal-regulated kinase/mitogen-activated (ERK/ MAPK) signaling and subsequent cell-cycle arrest [7-9].”
BackgroundSelf-citationCai, Z., Luo, W., Wang, H., Zhu, R., Yuan, Y., Zhan, X., Xie, M., Zhuang, H., Chen, H., Xu, Y., et al. (2024) · Cancer Science · doi:10.1111/cas.16151 · Cited by 12
“Since MFN2 has been identified as an important protein that promotes mitochondrial fusion, 11,19 we stained cells with a green fluorescence dye MitoTracker to label mitochondria and found that cells with suppressed levels of MFN2 had significantly shorter mitochondrial fragments (Figure 3C,D).”
BackgroundLou, Y., Zhang, Y., Li, R., Gu, P., Xiong, L., Zhong, H., Zhang, W., & Han, B. (2016) · Tumor Biology · doi:10.1007/s13277-015-4702-6 · Cited by 10
“was found in hyper-proliferative vascular smooth muscle cells (VSMCs) of hypertensive rat arteries [6].”
BackgroundTributyltin Inhibits Neural Induction of Human Induced Pluripotent Stem Cells
Yamada, S., Kubo, Y., Yamazaki, D., Sekino, Y., Nomura, Y., Yoshida, S., & Kanda, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-30615-2 · Cited by 10
Effects of mitofusin-2 gene on cell proliferation and chemotherapy sensitivity of MCF-7
Xia, Y. F., Wu, Y., He, X., Gong, J., & Qiu, F. (2008) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-008-0218-2 · Cited by 10
Zhang, Z., Zhou, X., Mei, Y., Bu, X., Tang, J. T., Gong, T., Liu, G., Cai, S., Ren, Y., & Mu, L. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1219381 · Cited by 14
“Patients with comorbid hypertension and diabetes have a significantly increased risk of cardiovascular and cerebrovascular events (3) and greater renal impairment than those with hypertension or diabetes alone (4).”
Self-citationInagaki, S., Suzuki, Y., Kawasaki, K., Kondo, R., Imaizumi, Y., & Yamamura, H. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00274.2021 · Cited by 12
Guo, Y., Fan, Y., Zhang, J., Chang, L., Lin, J. D., & Chen, Y. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407452 · Cited by 10
“Overexpression of PGC-1 Prevents Neointima Formation in Balloon-injured Carotid Arteries in Rats—To determine whether PGC-1 modulates the development of neointima formation, PGC-1 was overexpressed in the common carotid artery immediately after balloon injury by adenovirus-mediated gene delivery (5, 33).”
BackgroundMethodInfluentialSelf-citationWang, X., Zhu, Z., Jia, H., Lu, X., Zhang, Y., Zhu, Y., Wang, J., Wang, Y., Tan, R., & Yuan, J. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003704 · Cited by 11
“[80] Overexpression of MFN2 in PASMCs of PAH patients can promote fusion, reduce mitochondrial fragmentation, reduce the proliferation of PASMCs, and increase apoptosis.”
Hu, X., Lei, X., Wang, J., PAN, H., Li, C., & Yao, Z. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1835 · Cited by 8
“Moreover, a previous study indicated that adenoviral gene transfer of rMfn2 inhibited the mitogenic stimuli-mediated proliferation of cultured Wistar-Kyoto vascular smooth muscle cells, blocked balloon injury-induced neointimal vascular smooth muscle cell proliferation and restenosis in vivo , and had a potent antipro…”
InfluentialAltered expression of mitofusin 2 in penile tissues of diabetic rats
Yang, J., Wang, T., Zhang, Y., Li, R., Wang, S., Xu, H., Liu, J., & Ye, Z. (2013) · Andrologia · doi:10.1111/and.12108 · Cited by 8
“Between them, Mfn2 was first discovered through mRNA mapping analysis by Chen et al. (2004).”
BackgroundExpression of HSG is essential for mouse blastocyst formation
Jiang, G., Pan, L., Huang, X.-Y., Han, M. H., Wen, J., & Sun, F.-Z. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.088 · Cited by 9
Han, J., Liu, J., Zhou, Q. G., Nie, S., Liu, J., & Wen, S. (2019) · Medical Science Monitor · doi:10.12659/msm.915272 · Cited by 7
“Other oxidative factors produced by mitochondria are thought to lead to atherosclerosis and hypertension [22].”
BackgroundSelf-citationBagshaw, O. R. M., Moradi, F., Moffatt, C., Hettwer, H. A., Liang, P., Goldman, J., Drelich, J. W., & Stuart, J. A. (2021) · Biomaterials and Biosystems · doi:10.1016/j.bbiosy.2021.100027 · Cited by 9
Mitochondrial Metabolism and Insulin Action
Turner, N. A. (2013) · InTech eBooks · doi:10.5772/56449 · Cited by 13
“of mitofusin 2 (MFN2), which appears to have additional pleitropic effects in cells beyond the maintenance of the mitochondrial network [148-152], is reduced in the skeletal muscle of obese insulin-resistant humans, type 2 diabetic humans and diabetic Zucker rats [149,153] and correlates with the capacity for glucose…”
BackgroundQu, L., Chen, H., Wang, G., & Wei, J. (2013) · Tumori Journal · doi:10.1177/030089161309900609 · Cited by 7
Mitochondrial quality control in health and disease: mechanisms and therapeutic targets
Creus, A., Mohapatra, S., Ortega, L., & Sebastián, D. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02813-2 · Cited by 13
Wang, Y., Han, D. H., Chai, L., Qiu, Y., Liu, J., Li, D., Zhang, Q., Chen, Y., Chen, Y., Chen, H., et al. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176828 · Cited by 6
Endosomal RFFL ubiquitin ligase regulates mitochondrial morphology by targeting mitofusin 2
Narendradev, N. D., Ravindran, R., Jain, P., Chaudhary, S., Velikkakath, A. K. G., Sudharman, A., Janardhanan, A., Nag, T. C., Yadav, S. C., & Srinivasula, S. M. (2025) · Journal of Cell Science · doi:10.1242/jcs.263830 · Cited by 7
AKAP350C targets to mitochondria via a novel amphipathic alpha helical domain
Mason, T. A., Goldenring, J. R., & KOLOBOVA, E. A. (2014) · Cellular Logistics · doi:10.4161/21592780.2014.943597 · Cited by 7
Metadata
- Authors
- Chen, K.-H., Guo, X., Ma, D., Guo, Y., Li, Q., Yang, D., Li, P., Qiu, X., Wen, S., Xiao, R.-P., & Tang, J.
- Affiliations
- National Institutes of Health (US)
- Peking University (CN)
- Corresponding author
- Xiao, Rui-Ping
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2004-08-22
- Volume
- 6
- Issue
- 9
- Pages
- 872-883
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2104828119
- Cited by
- 370
- References
- 50
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 6 · 2023: 12 · 2022: 26 · 2021: 22 · 2020: 18 · 2019: 19 · 2018: 22 · 2017: 18 · 2016: 21 · 2015: 24 · 2014: 20 · 2013: 32 · 2012: 26
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Keywords
- HSG, mitofusin 2, vascular smooth muscle cell proliferation, restenosis, intimal hyperplasia, atherosclerosis, ERK/MAPK signalling, cell cycle arrest, mitochondrial targeting, mitochondrial fusion, spontaneously hypertensive rats, balloon injury, ApoE-deficient mice
- MeSH terms
- Animals, Arteriosclerosis, Cardiovascular Diseases, Cell Division, Gene Expression Regulation, Humans, Membrane Proteins, Molecular Sequence Data, Muscle, Smooth, Vascular, Oncogene Protein p21(ras), Mice, Knockout, GTP Phosphohydrolases, MAP Kinase Signaling System, Coronary Restenosis, Mitochondrial Proteins, Myocytes, Smooth Muscle, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.